Skip to Content
Wichai  Chinratanalab

Wichai Chinratanalab, M.D.

Assistant Professor of Medicine

  • Appointments
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Nashville Veterans Affairs Medical Center
    (615) 327-4751 or (800) 228-4973

  • Faxes
    Nashville Veterans Affairs Medical Center Fax
    (615) 873-7901

    Clinic Fax
  • Addresses
    Vanderbilt University Medical Center
    1301 Medical Center Drive, 3903 TVC
    Nashville, TN 37232-5505

    Nashville Veterans Affairs Medical Center
    1310 24th Ave. South
    Nashville , TN 37212-2637

  • Pramongkutklao College of Medicine, Mahidol University, Bangkok, Thailand, M.D., 1990
  • Medical Resident, Pramongkutklao Hospital, Mahidol University, Bangkok, Thailand, 1991-1994
  • Medical Resident, Texas Tech University Health Sciences Center, 1994-1997
  • Clinical Fellow (Hematology/Oncology), Vanderbilt University Medical Center, 1997-2000
  • Clinical Fellow (Bone Marrow Transplantation), Vanderbilt University Medical Center, 2000-2001
  • Sengsayadeth S, Savani BN, Jagasia M, Goodman S, Greer JP, Chen H, Chinratanalab W, Kassim AA, Engelhardt BG. Six-month freedom from treatment failure is an important end point for acute GVHD clinical trials. Bone Marrow Transplant [print-electronic]. 2014 Feb; 49(2): 236-40. PMID: 24096824, PMCID: PMC3946331, PII: bmt2013157, DOI: 10.1038/bmt.2013.157, ISSN: 1476-5365.
    Available from:
  • Vaughan LA, Vu M, Sengsayadeth S, Lucid C, Clifton C, McCarty K, Hagaman D, Domm J, Kassim A, Chinratanalab W, Goodman S, Greer J, Frangoul H, Engelhardt BG, Jagasia M, Savani BN. New allergies after cord blood transplantation. Cytotherapy. 2013 Oct; 15(10): 1259-65. PMID: 23993300, PII: S1465-3249(13)00550-1, DOI: 10.1016/j.jcyt.2013.05.018, ISSN: 1477-2566.
    Available from:
  • Chinratanalab W, Reddy N, Greer JP, Morgan D, Engelhardt B, Kassim A, Brandt SJ, Jagasia M, Goodman S, Savani BN. Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies. Exp. Hematol [print-electronic]. 2012 Jun; 40(6): 431-5. PMID: 22269114, PMCID: PMC4067702, PII: S0301-472X(12)00016-1, DOI: 10.1016/j.exphem.2012.01.014, ISSN: 1873-2399.
    Available from:
  • Reddy N, Greer JP, Goodman S, Kassim A, Morgan DS, Chinratanalab W, Brandt S, Englehardt B, Oluwole O, Jagasia MH, Savani BN. Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen. Exp. Hematol [print-electronic]. 2012 May; 40(5): 359-66. PMID: 22269117, PII: S0301-472X(12)00014-8, DOI: 10.1016/j.exphem.2012.01.012, ISSN: 1873-2399.
    Available from:
  • Tedeschi SK, Jagasia M, Engelhardt BG, Domm J, Kassim AA, Chinratanalab W, Greenhut SL, Goodman S, Greer JP, Schuening F, Frangoul H, Savani BN. Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation. Cytotherapy [print-electronic]. 2011 Jan; 13(1): 78-82. PMID: 20586668, DOI: 10.3109/14653249.2010.495114, ISSN: 1477-2566.
    Available from:
  • Jagasia MH, Savani BN, Stricklin G, Engelhardt B, Kassim A, Dixon S, Chen H, Chinratanalab W, Goodman S, Greer JP, Schuening F. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol. Blood Marrow Transplant [print-electronic]. 2009 Oct; 15(10): 1288-95. PMID: 19747637, PMCID: PMC3159406, PII: S1083-8791(09)00289-4, DOI: 10.1016/j.bbmt.2009.06.007, ISSN: 1523-6536.
    Available from:
  • Savani BN, Pohlmann PR, Jagasia M, Chinratanalab W, Kassim A, Engelhardt B, Greer J, Schuening F, Goodman S. Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD? [letter]. Blood. 2009 Jun 6/11/2009; 113(24): 6263-4. PMID: 19520823, PII: 113/24/6263, DOI: 10.1182/blood-2009-04-213892, ISSN: 1528-0020.
    Available from:
  • Jagasia M, Giglia J, Chinratanalab W, Dixon S, Chen H, Frangoul H, Engelhardt B, Goodman S, Greer J, Kassim A, Morgan D, Ruffner K, Schuening F. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol. Blood Marrow Transplant [print-electronic]. 2007 Oct; 13(10): 1207-15. PMID: 17889358, PII: S1083-8791(07)00338-2, DOI: 10.1016/j.bbmt.2007.07.001, ISSN: 1083-8791.
    Available from:
  • Engelhardt BG, Holland DW, Brandt SJ, Chinratanalab W, Goodman SA, Greer JP, Jagasia MH, Kassim AA, Morgan DS, Ruffner KL, Schuening FG, Wolff S, Bitting R, Sulur P, Stein RS. High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes. Leuk. Lymphoma. 2007 Sep; 48(9): 1728-35. PMID: 17786708, PII: 781802102, DOI: 10.1080/10428190701534374, ISSN: 1042-8194.
    Available from:
  • Kassim AA, Chinratanalab W, Ferrara JL, Mineishi S. Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: 'what is the best recipe?'. Bone Marrow Transplant. 2005 Oct; 36(7): 565-74. PMID: 15995714, PII: 1705075, DOI: 10.1038/sj.bmt.1705075, ISSN: 0268-3369.
    Available from:
  • Akpek G, Chinratanalab W, Lee LA, Torbenson M, Hallick JP, Anders V, Vogelsang GB. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. Biol. Blood Marrow Transplant. 2003 Jan; 9(1): 46-51. PMID: 12533741, PII: S1083879102000022, DOI: 10.1053/bbmt.2003.49999, ISSN: 1083-8791.
    Available from:
  • Yakes FM, Chinratanalab W, Ritter CA, King W, Seelig S, Arteaga CL. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action. Cancer Res. 2002 Jul 7/15/2002; 62(14): 4132-41. PMID: 12124352, ISSN: 0008-5472.
    Available from:
  • Arteaga CL, Chinratanalab W, Carter MB. Inhibitors of HER2/neu (erbB-2) signal transduction. Semin. Oncol. 2001 Dec; 28(6 Suppl 18): 30-5. PMID: 11774203, PII: asonc02806p0030, ISSN: 0093-7754.
    Available from: